(Q40098056)

17 September 2017

title

PKC 412 small-molecule tyrosine kinase inhibitor: single-compound therapy for pancreatic cancer (English)

1 reference

17 September 2017

1 reference

6

Markus W Büchler

1 reference

17 September 2017

10

Helmut Friess

1 reference

17 September 2017

7

Hilmar Quentmeier

1 reference

17 September 2017

1

Jamael El Fitori

1 reference

17 September 2017

3

Peter Büchler

1 reference

17 September 2017

8

Oscar J Hines

1 reference

17 September 2017

9

Ingrid Herr

1 reference

17 September 2017

Yun Su

2

1 reference

17 September 2017

Roman Ludwig

series ordinal

4

1 reference

17 September 2017

Nathalia A Giese

series ordinal

5

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

110

1 reference

17 September 2017

issue

7

1 reference

17 September 2017

page(s)

1457-1468

1 reference

Effects of FLT3 ligand on proliferation and survival of myeloid leukemia cells

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

Flt-3 and its ligand are expressed in neural crest-derived tumors and promote survival and proliferation of their cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

VEGF-RII influences the prognosis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

FLT3 mutations in acute myeloid leukemia cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Mini ReviewFLT3: Receptor and Ligand

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Prospective study of 174 de novo acute myelogenous leukemias according to the WHO classification: subtypes, cytogenetic features and FLT3 mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Effect of Flt3 ligand gene transfer in experimental pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

The Notch signaling pathway is related to neurovascular progression of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Pancreatic cancer--new aspects of molecular biology research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Genomic structure of human FLT3: implications for mutational analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Pancreatic cancer growth is inhibited by blockade of VEGF-RII.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22931

7 January 2021

Identifiers

DOI

10.1002/CNCR.22931

1 reference

17 September 2017

1 reference